Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.
Saved in:
| Title: | Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. |
|---|---|
| Authors: | Miura, Yu1 (AUTHOR), Imai, Hisao1,2 (AUTHOR) m06701014@gmail.com, Endo, Satoshi2,3 (AUTHOR), Hashimoto, Kosuke1,4 (AUTHOR), Yamaguchi, Ou1 (AUTHOR), Mouri, Atsuto1 (AUTHOR), Masubuchi, Ken2 (AUTHOR), Masubuchi, Takeshi2 (AUTHOR), Fujita, Yuka3 (AUTHOR), Kato, Shingo4 (AUTHOR), Kagamu, Hiroshi1 (AUTHOR), Kaira, Kyoichi1 (AUTHOR) |
| Source: | Current Oncology. Mar2026, Vol. 31 Issue 3, p135. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
